Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Disclosed deployed
—
across known amounts
Stages
—
About
OrbiMed is a dedicated healthcare investment firm with investments ranging from biopharmaceuticals to medical devices, diagnostics, and healthcare services. The firm invests across the global healthcare industry, from seed-stage venture capital to large, publicly traded companies. Investments are made through public equity, private equity, or royalty opportunities.
OrbiMed was founded in 1989 and is headquartered in New York, with offices in San Francisco, Mumbai, Hong Kong, and Shanghai.
Portfolio
No portfolio companies in this dataset yet.
Investor Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is OrbiMed's primary investment focus?
- OrbiMed is a dedicated healthcare investment firm, focusing on biopharmaceuticals, medical devices, diagnostics, and healthcare services globally. They invest across the entire spectrum, from seed-stage venture capital to large, publicly traded companies.
- What was OrbiMed's most recent fundraise?
- According to startupim data, OrbiMed raised $4.3 billion across private investment funds in October 2023.
- Can you name some of OrbiMed's notable portfolio companies and their recent investment activities?
- OrbiMed has recently invested $105 million in Magenta Medical in July 2024 and $50 million in Biobeat in January 2026. For a full list of their portfolio, please refer to startupim.
- What is OrbiMed's activity in leading investment rounds?
- OrbiMed has led several investment rounds, including a $58 million investment in InspireMD in August 2025 and a $55 million investment in Magenta Medical in May 2023.
- Has OrbiMed had any significant exits recently?
- Yes, ImmPACT Bio was acquired by Lyell Immunopharma in October 2024. Additionally, Chemomab Therapeutics completed a reverse merger in March 2021, listing on NASDAQ.
- What is OrbiMed's stance on raising Israeli healthcare-dedicated funds?
- In January 2021, OrbiMed chose against raising a third Israeli healthcare-dedicated fund, as reported by calcalistech.com.
- When was OrbiMed founded and where is it headquartered?
- OrbiMed was founded in 1989 and is headquartered in New York, with additional offices in San Francisco, Mumbai, Hong Kong, and Shanghai.
- What is the range of investment amounts for OrbiMed?
- OrbiMed's investment range is from $2.25 million to $200 million.